文献速递其他结缔组织病

幼年性与成人特发性炎症性肌病自身抗体表型及长期结局的差异

Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies.
PubMed 文献 · Semin Arthritis Rheum · 2024-08-08

这项回顾性研究分析了320例日本特发性炎症性肌病患者(幼年性34例、成人286例),比较两组自身抗体分布、临床特征及最长20年无药状态。幼年性组累积无药状态率高于成人组(34% vs 18%,p=0.0016),特定自身抗体与不同临床特征及结局相关。

要点

  • 幼年性IIM累积无药状态率高于成人IIM(34% vs 18%,p=0.0016)。
  • 抗TIF1-γ阳性幼年性IIM较成人IIM肌肉症状少、恶性肿瘤少、激素使用少。
  • 抗MDA-5阳性两组均常见无肌病性皮肌炎、ILD及多药免疫抑制治疗,无药状态率相近。

核心结论

  • 幼年性IIM患者较成人IIM患者更常达到无药状态。
  • 特定自身抗体与幼年性IIM和成人IIM的不同临床特征及结局相关。

研究设计与样本

  • 回顾性分析320例日本IIM患者(幼年性IIM 34例,成人IIM 286例),使用京都大学注册数据库,自身抗体、临床特征及最长20年无药状态被分析。

主要发现

  • 幼年性IIM中观察到的自身抗体为抗TIF1-γ(15%)、抗MDA-5(15%)、抗ARS(9%)和抗NXP-2(6%)。
  • 成人IIM中观察到的自身抗体为抗ARS(32%)、抗MDA-5(23%)、抗TIF1-γ(8%)、抗SRP(8%)、抗Mi-2(2%)和抗NXP-2(1%)。
  • 幼年性IIM较成人IIM的累积无药状态率更高(34% vs 18%,p=0.0016)。
  • 抗TIF1-γ阳性者中,幼年性IIM较成人IIM肌肉症状更少(60% vs 90%)、恶性肿瘤更少(0% vs 57%)、糖皮质激素使用更少(40% vs 86%),且幼年性IIM更多达到无药状态(60% vs 25%)。
  • 抗MDA-5阳性两组均常见无肌病性皮肌炎、ILD及多药免疫抑制治疗,无药状态率分别为50% vs 49%;抗ARS阳性两组均常见皮疹、肌肉症状、ILD及多药免疫抑制治疗,无药状态率低(0% vs 3%);抗NXP-2阳性两组均常见皮疹、肌肉症状、ILD频率低、常用甲氨蝶呤和糖皮质激素,均未达到无药状态(0% vs 0%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate differences in autoantibodies, clinical features, and long-term outcomes between juvenile-idiopathic inflammatory myopathy (IIM) and adult-IIM METHODS: Autoantibodies, clinical characteristics, and drug-free conditions for a maximum of 20 years were retrospectively analyzed in 320 Japanese IIM patients (juvenile-IIM, n = 34; adult-IIM, n = 286) using the Kyoto University Registry. RESULTS: Autoantibodies observed in juvenile-IIM were anti-TIF1-γ (15 %), anti-MDA-5 (15 %), anti-ARS (9 %), and anti-NXP-2 (6 %). Those observed in adult-IIM were anti-ARS (32 %), anti-MDA-5 (23 %), anti-TIF1-γ (8 %), anti-SRP (8 %), anti-Mi-2 (2 %), and anti-NXP-2 (1 %). The cumulative drug-free condition rate was higher in juvenile-IIM than in adult-IIM up to 20 years (juvenile-IIM vs. adult-IIM, 34 % vs. 18 %, p = 0.0016). Anti-TIF1-γ was associated with lesser muscle symptoms (60 % vs. 90 %), malignancy (0 % vs. 57 %), and glucocorticoid use (40 % vs. 86 %) in juvenile-IIM compared to adult-IIM, while juvenile-IIM more achieved drug-free conditions (60 % vs. 25 %). Both juvenile-IIM and adult-IIM with anti-MDA-5 demonstrated a high frequency of amyopathic dermatomyositis, interstitial lung disease (ILD), and multi-immunosuppressive therapy, with high drug-free conditions (50 % vs. 49 %). Both juvenile-IIM and adult-IIM with anti-ARS showed frequent skin rashes, muscle symptoms, and ILD, frequent need for multi-immunosuppressive therapy, and low drug-free condition rates (0 % vs. 3 %). Both juvenile-IIM and adult-IIM with anti-NXP-2 showed frequent skin rashes and muscle symptoms, low ILD frequency, and frequent use of methotrexate and glucocorticoids, which did not achieve drug-free conditions (0 % vs. 0 %). CONCLUSIONS: Drug-free condition was achieved more frequently in juvenile-IIM patients than adult-IIM patients. Specific autoantibodies were associated with different clinical characteristics and outcomes between juvenile-IIM and adult-IIM.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Tsuji H, Nakashima R, Yasumi T, et al. Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies. Semin Arthritis Rheum. 2024. PMID: 39142036. doi:10.1016/j.semarthrit.2024.152530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。